World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-6c2k3m
Date of registration: 16/04/2012
Primary sponsor: Universidade de São Paulo - São Paulo, PR, Brazil
Public title: Evaluation of two types of implants installed in the jaw
Scientific title: A comparative study of marginal bone variation around Titanium-13Zirconium and versus Titanium Grade IV.
Date of first enrolment: 02/05/2011
Target sample size: 12
Recruitment status: recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-6c2k3m/
Study type: 
Study design:  Therapeutic, parallel, with two arms, double-blinded, randomized-controlled clinical trial  
Countries of recruitment
Brazil
Contacts
Name: Lívia  Tolentino
Address:  Avenida Prof Lineu Prestes 05508-000 Sao Paulo Brazil
Telephone: 55-11 3091-7840
Email: liviatolentino85@gmail.com
Affiliation:  Universidade de São Paulo
Name: Lívia  Tolentino
Address:  Avenida Prof Lineu Prestes 05508-000 Sao Paulo Brazil
Telephone: 55-11 3091-7840
Email: liviatolentino85@gmail.com
Affiliation:  Universidade de São Paulo
Key inclusion & exclusion criteria
Inclusion criteria: To sign voluntary informed consent for using his/her data;
At least 18 years-old;
Posterior edentulous areas that needed at least 2 implants in the maxilla, or 2 implants in the mandible
To have a posterior area to receive one narrow implant diameter at least 8 weeks to implant installation;
5 mm of ridge width and 8 mm of lengh; These implants had to receive one single-crown rehabilitation and to have a antagonist tooth
1 year of follow up.

Exclusion criteria: Presence of sistemic problems, ex. diabetes
Use of any drug that could affect bone metabolism (biphosphonates);
Tobacco abuse (> 10 cigarettes/day);
Presence of immunocompromising conditions (HIV-positive, AIDS, or under therapy with immunosuppressive drugs);
Disability that interferes with the ability of a suitable cleaning;
History of radiotherapy of the head/neck region .
Pregnancy or lactating;
Condition or circumstance that may lead patients to abandon the study;
Presence of untreated periodontitis;
Soft and/or hard tissues alterations;
Previous bone augmentation procedure in the same place to fixture installation;
Presence of parafunctional habits;


Age minimum: 18Y
Age maximum: 80Y
Gender: -
Health Condition(s) or Problem(s) studied
Patients with partially edentulous jaw that need to be restored with single crowns
C05.500.480.450
Intervention(s)
12 SLActive® Implants (Control Group) and 12 Roxolid® Implants (Test Group)(Straumann® Dental Implant System, Basel, Switzerland), both with 3.3 diameter and platform 4.8 mm were installed in the posterior region of the jaw in 12 healthy patients. The patients received, randomly, in contralateral regions, one implant of each diameter in the mandible. Neither the patient nor the clinical know what type of implant was installed in each region. The patients received the implants, 6 weeks after received the protheses and periapical radiographs and computed tomography scans were performed 1 year after the prostheses were in function.
Primary Outcome(s)
Comparison of the bone level between TiZr and Ti after 1 year of clinical, radiogrphically and tomographically follow up.It is expected that after the follow up the Titanium-Zirconium implants provide a higher success rate
Secondary Outcome(s)
Reduced in the failure of the prosthesis in Titanium Zirconium implants after 1 year of follow up through the clinical analysis of fractures in prosthetic components and / or remission of the screws.
Secondary ID(s)
0025.0.107.000-11
Source(s) of Monetary Support
Universidade de São Paulo - São Paulo, PR, Brazil
Secondary Sponsor(s)
Universidade de São Paulo - São Paulo, PR, Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history